|
Figures in € thousand |
31 Dec. 2011 |
31 Dec. 2010 | ||
| ||||
|
Current market values for |
|
| ||
|
Shares in affiliated companies of minor importance1) |
21,845 |
21,235 | ||
|
Shares in associated companies of minor importance |
3,574 |
3,574 | ||
|
|
|
| ||
|
Book values for |
|
| ||
|
Shares in associated companies valued at equity |
526,911 |
542,870 | ||
|
|
|
| ||
|
Equity for |
|
| ||
|
Shares in affiliated companies of minor importance |
22,959 |
21,595 | ||
|
|
|
| ||
|
Annual net profit/loss for the year |
|
| ||
|
Shares in affiliated companies of minor importance |
1,189 |
1,508 | ||
The deterioration in the shares in associated companies was mainly due to the depreciation of Medicur-Holding Gesellschaft m.B.H. and Valida Holding AG.
|
Shares in associated companies |
31 Dec. 2011 |
|
Figures in € thousand |
|
|
Current market value of associated companies listed on a public stock exchange |
373,455 |
|
Profits/losses for the period |
13,522 |
|
Unrecorded, proportional loss, ongoing, if shares of loss are no longer recorded |
0 |
|
Unrecorded, proportional loss, cumulative, if shares of loss are no longer recorded |
0 |
|
Proportional asset value of shares in associated companies valued at equity |
1,813,765 |
|
Proportional liabilities of shares in associated companies valued at equity |
1,288,158 |
